SDC1 and central nervous system cancer: In glioma cells, YKL‐40 promotes the formation of the bond between SDC1 and αvβ5 and further activates the ERK1/2 pathway through FAK397, thereby increasing the expression of VEGF and promoting angiogenesis [27].